• Multiple studies presented in virtual 2020 ASCO Annual Meeting highlight the impact of QIAGEN’s Sample to Insight portfolio on improving knowledge about cancer and improving patient outcomes • QCI Interpret One combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients • QIAseq Pan-cancer Multimodal […]
Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made available after full closing. Oxford Nanopore’s sequencing devices are used […]
Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group” or “the Company”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”), has announced that it is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. […]
HSINCHU, Taiwan — Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a patent infringement complaint in the Wuhan People’s Court in China against Pacific Biosciences of California, Inc. (“PacBio”). The complaint asserts that PacBio’s Sequel and Sequel II, as well as related commercialization activities by PacBio, its agents and certified service providers, infringe one or more […]
Leading PCR and qPCR technology now available for high-throughput applications: With the Biometra TRobot IIand qTOWER³ auto, Analytik Jena presents two new thermal cyclers for fully automated PCR and qPCR applications. Both systems follow a modular approach and are designed as open systems. Both devices are particularly robust and were developed for unattended continuous operation. Customers of […]
New solution accelerates research validation in cancer, immunology and drug discovery PLEASANTON, Calif. — Building on its earlier reveal at the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG) today launched its Targeted Gene Expression Solution for single cell and shortly following for spatial genomic research. Targeted Gene Expression […]
Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® […]
BEIJING–(BUSINESS WIRE)– Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI. The partnership will support DARUI at developing pathogenic microorganism detection products and applying for registration of reagent kits using the NGS sequencer GENETRON S5 (Registration Number 20193220820). Featuring diverse application […]
Lexogen and BlueBee have launched a new, web-based data analysis portal to provide a more user‑friendly experience for Lexogen kit users analyzing RNA sequencing data. With the Lexogen web solution configuration on the BlueBee Genomics Platform, data upload is easier than ever— files can be uploaded with a simple “drag and drop” function (Figure 1) […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
